11936462 ACCOPHARM CLINICAL TRIAL SERVICES LIMITED false 2023-05-01 2024-04-30 2024-04-30 false The principal activity of the company is other professional, scientific and technical activities n.e.c. 11936462 uk-bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 11936462 2023-05-01 2024-04-30 11936462 uk-bus:RegisteredOffice 2023-05-01 2024-04-30 11936462 2022-05-01 2023-04-30 11936462 uk-bus:Micro-entities 2023-05-01 2024-04-30 11936462 uk-bus:FullAccounts 2023-05-01 2024-04-30 11936462 uk-bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 11936462 2024-04-30 11936462 uk-core:WithinOneYear 2024-04-30 11936462 uk-core:AfterOneYear 2024-04-30 11936462 2023-04-30 11936462 uk-core:WithinOneYear 2023-04-30 11936462 uk-core:AfterOneYear 2023-04-30 11936462 uk-bus:Director1 2023-05-01 2024-04-30 11936462 uk-bus:Director1 2024-04-30 iso4217:GBP shares pure
Registered number: 11936462
ACCOPHARM CLINICAL TRIAL SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024
PAGES FOR FILING WITH REGISTRAR
ACCOPHARM CLINICAL TRIAL SERVICES LIMITED

BALANCE SHEET
AS AT 30 APRIL 2024
2024 2023
£ £
Current assets 164,725 215,778
Creditors: amounts falling due within one year (22,811) (64,513)
Net current assets / (liabilities) 141,914 151,265
Total assets less current liabilities 141,914 151,265
Creditors: amounts falling due after more than one year (35,453) (44,825)
Net assets / (net liabilities) 106,461 106,440
Capital and reserves 106,461 106,440

Notes to the financial statements:

  1. Average number of employees

    During the year the average number of employees, including directors, was 1 (2023: 1).

ACCOPHARM CLINICAL TRIAL SERVICES LIMITED (11936462) is a private company limited by shares incorporated in England and Wales. The registered office address is Arquen House 4-6, Spicer Street, St. Albans, AL3 4PQ, England.

For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with section 476 of the Companies Act 2006.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with micro-entity provisions and with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies' regime. The income statement has not been delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 31 January 2025  and are signed on its behalf by:

Olushola Eniola AYENI
Director
Company registration number: 11936462